title: Comparison of Post-Authorisation Measures From Regulatory Authorities With Additional Evidence Requirements From HTA Bodies in Germany.
authors.affiliation: Roche Pharma, Grenzach-Wyhlen, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Ruof
authors.affiliation: Roche Pharma, Grenzach-Wyhlen, Germany.
authors.forename: T R
authors.initials: TR
authors.lastname: Staab
authors.affiliation: Bristol-Myers Squibb GmbH und Co. KGaA, Munich, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Slawik
authors.affiliation: vfa, Berlin, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Orben
authors.affiliation: Bayer Business Service GmbH, Leverkusen, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Bosch